Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 7Sanofi
02 1Shire Human Genetic Therapies AB
03 2Takeda Pharmaceutical
01 1INF
02 1KONCENTRAT TILL INFUSIONSVÄTSKA, LÖSNING
03 2POI
04 1POWDER FOR CONCENTRATE FOR
05 2POWDER FOR SOLUTION
06 1SOLUTION
07 2VIAL; INTRAVENOUS
01 3Originator
02 7Blank
01 4FABRAZYME
02 1Fabrazyme
03 1Fabrazyme 35mg
04 1Fabrazyme 5mg
05 1REPLAGAL
06 2Replagal
01 3Canada
02 3South Africa
03 2Sweden
04 2USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : FABRAZYME
Dosage Form : VIAL; INTRAVENOUS
Dosage Strength : 5MG/VIAL
Packaging :
Approval Date :
Application Number : 103979
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : FABRAZYME
Dosage Form : VIAL; INTRAVENOUS
Dosage Strength : 35MG/VIAL
Packaging :
Approval Date :
Application Number : 103979
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : Fabrazyme
Dosage Form : POWDER FOR CONCENTRATE FOR
Dosage Strength : -
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Canada
Brand Name : FABRAZYME
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 5MG/VIAL
Packaging : 1.1ML
Approval Date :
Application Number : 2248965
Regulatory Info :
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Canada
Brand Name : FABRAZYME
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 35MG/VIAL
Packaging : 7.2ML
Approval Date :
Application Number : 2248966
Regulatory Info :
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fabrazyme 35mg
Dosage Form : POI
Dosage Strength : 35mg/20ml
Packaging : 20X1mg/20ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Fabrazyme 5mg
Dosage Form : POI
Dosage Strength : 5mg/5ml
Packaging : 5X1mg/5ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Canada
Brand Name : REPLAGAL
Dosage Form : SOLUTION
Dosage Strength : 1MG/ML
Packaging :
Approval Date :
Application Number : 2249057
Regulatory Info :
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Replagal
Dosage Form : INF
Dosage Strength : 1mg/ml
Packaging : 3.5X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info :
Registration Country : Sweden
Brand Name : Replagal
Dosage Form : KONCENTRAT TILL INFUSIONSVÄTSKA, LÖSNING
Dosage Strength : 1 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
